Effectiveness of a Natural Ingredient on Appetite Regulation

NCT ID: NCT04345029

Last Updated: 2020-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-15

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Single-center, double-blind, double-crossed, randomized controlled clinical trial with two crossed branches, designed with the objective of evaluating the effect of the investigational product on satiety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects who meet the selection criteria will make a total of five visits to the research laboratory and will carry out the tests established in the protocol. Subsequently, a statistical analysis will be performed with the variables measured in the study to obtain results.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Appetite Regulation Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group (Lippia citriodora + sabdariffa)

Consumption for 60 days of Lippia citriodora 325 mg + Hibiscus sabdariffa 175 mg.

Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.

Group Type EXPERIMENTAL

Dietary supplement consumption

Intervention Type DIETARY_SUPPLEMENT

The experimental product consumption time was 60 days and the control consumption time was 60 days.

Each subject must consume both products, with a washing period of 30 days.

control group Placebo (sucrose)

Two capsules per day will be consumed thirty minutes before breakfast orally for 60 days.

Group Type PLACEBO_COMPARATOR

Dietary supplement consumption

Intervention Type DIETARY_SUPPLEMENT

The experimental product consumption time was 60 days and the control consumption time was 60 days.

Each subject must consume both products, with a washing period of 30 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary supplement consumption

The experimental product consumption time was 60 days and the control consumption time was 60 days.

Each subject must consume both products, with a washing period of 30 days.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18-65 years.
* Both genders.
* BMI 25-34.9 kg / m2, both inclusive.
* Weight maintained during the last 3 months.
* Smoking subjects or not, but in any case they do not change their nicotinic habits during their participation in the study.
* Absence of disease diagnosed at the start of the study.

Exclusion Criteria

* Thyroid dysfunction, infections, or with any type of chronic disease (eg, autoimmune, inflammatory).
* History of allergic hypersensitivity or poor tolerance to any component of the products under study.
* Subjects who are performing or intend to carry out any type of diet, low-calorie or not, during the study.
* Participation in another clinical trial in the three months prior to the study.
* Lack of will or inability to comply with clinical trial procedures.
* Pregnant woman.
* Subjects whose condition does not make them eligible for the study according to the researcher's criteria.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Católica San Antonio de Murcia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francisco Javier López Román

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Catholic University of Murcia

Murcia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UCAMCFE-00012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.